Deutsche Bank analyst George Hill lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps a Hold rating on the shares post the Q3 report.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter